In medicine, it's a common theme -- the signs of many devastating diseases are present at onset, but often aren't detected until the disease has reached an advanced state and treatment options are limited. Many complex clinical problems require a fundamental shift in approach. The goal at Ravgen is to revolutionize diagnosis and the treatment of human diseases through innovative technologies.

The key to early diagnosis and improved treatment lies in separating relevant, disease-associated genetic signals from the background of non disease-associated signals. The Ravgen method (Rapid analysis of variations in a genome) eclipses background signals, shifting the focus toward genetic markers that are present at the earliest stages of a disease.

Ravinder Dhallan, a doctor and researcher, founded Ravgen in the fall of 2000 with the goal of solving major clinical problems. His experiences in biomedical engineering, clinical research and medicine have shaped the research and fueled innovation that can directly benefit patients.